Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Antonin Bal and Bruno Lina.
Antonin Bal
Connection Strength
2.359
Bruno Lina
  1. Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study. Sci Rep. 2021 07 22; 11(1):14977.
    View in: PubMed
    Score: 0.239
  2. Evaluation of High-Throughput SARS-CoV-2 Serological Assays in a Longitudinal Cohort of Patients with Mild COVID-19: Clinical Sensitivity, Specificity, and Association with Virus Neutralization Test. Clin Chem. 2021 04 29; 67(5):742-752.
    View in: PubMed
    Score: 0.236
  3. Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021. Euro Surveill. 2021 03; 26(9).
    View in: PubMed
    Score: 0.233
  4. Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays. Clin Microbiol Infect. 2021 Jun; 27(6):933-935.
    View in: PubMed
    Score: 0.231
  5. Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020. Euro Surveill. 2021 01; 26(3).
    View in: PubMed
    Score: 0.230
  6. Metagenomic Investigation of Torque Teno Mini Virus-SH in Hematological Patients. Front Microbiol. 2019; 10:1898.
    View in: PubMed
    Score: 0.211
  7. Emergence of enterovirus D68 clade D1, France, August to November 2018. Euro Surveill. 2019 Jan; 24(3).
    View in: PubMed
    Score: 0.201
  8. Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management. Viruses. 2018 11 14; 10(11).
    View in: PubMed
    Score: 0.199
  9. Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France. Emerg Microbes Infect. 2021 Dec; 10(1):167-177.
    View in: PubMed
    Score: 0.061
  10. Live virus neutralization testing in convalescent patients and subjects vaccinated against 19A, 20B, 20I/501Y.V1 and 20H/501Y.V2 isolates of SARS-CoV-2. Emerg Microbes Infect. 2021 Dec; 10(1):1499-1502.
    View in: PubMed
    Score: 0.061
  11. Correction: Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 Oct 04; 218(10).
    View in: PubMed
    Score: 0.060
  12. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J Exp Med. 2021 10 04; 218(10).
    View in: PubMed
    Score: 0.060
  13. Bamlanivimab as monotherapy in two immunocompromised patients with COVID-19. Lancet Microbe. 2021 Sep; 2(9):e424.
    View in: PubMed
    Score: 0.060
  14. Novel SARS-CoV-2 Variant Derived from Clade 19B, France. Emerg Infect Dis. 2021 05; 27(5):1540-1543.
    View in: PubMed
    Score: 0.059
  15. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation. Virus Evol. 2020 Jul; 6(2):veaa075.
    View in: PubMed
    Score: 0.057
  16. Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody. J Clin Virol. 2020 11; 132:104613.
    View in: PubMed
    Score: 0.056
  17. Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic. Lancet Microbe. 2020 Aug; 1(4):e149.
    View in: PubMed
    Score: 0.055
  18. How to manage chickenpox during pregnancy: case reports. Ann Biol Clin (Paris). 2018 Dec 01; 76(6):669-674.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.